The anxiety-reducing properties of the synthetic heptapeptide Semax, which is an analog of a fragment of adrenocorticotropic hormone (ACTH). Clinically, Semax is used to decrease subjective feelings of stress, worry, and tension while simultaneously maintaining or enhancing cognitive function. This anxiolytic action is distinct from general sedation, as the peptide is also known for its nootropic effects, making it a unique tool for managing performance-related anxiety.
Origin
Semax was developed in Russia based on the structure of the ACTH(4-10) fragment, leveraging the understanding that this hormonal fragment possesses significant neuro-regulatory activity independent of its adrenal-stimulating properties. The study of its ‘Anxiolytic Effects’ arose from early observations in clinical settings that the peptide not only improved cognition but also exerted a calming, stabilizing influence on the nervous system.
Mechanism
Semax exerts its anxiolytic effect primarily through its interaction with the brain’s monoamine systems, particularly by modulating the levels and turnover of serotonin and dopamine in the limbic system. It also acts as a potent regulator of neurotrophic factors, specifically increasing the expression of BDNF, which supports neuronal survival and plasticity in stress-sensitive brain regions. This combined action promotes a resilient, adaptive response to stress while preserving cognitive clarity.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.